GSK pledges further trial transparency
March 26, 2009Research and Development, Sales and Marketing GSK
GlaxoSmithKline is to make its clinical trials more transparent through a series of moves it believes will facilitate clinical research. …
NICE recommends Pfizer’s Sutent
March 26, 2009Research and Development NICE, Pfizer, Sutent
NICE has issued its final guidance on Pfizer's Sutent, recommending the kidney cancer drug as a first-line treatment. The drug …
GSK linked to Allergan takeover
March 26, 2009Sales and Marketing Allergan, GSK
GlaxoSmithKline may be considering a bid to buy Allergan, the company behind 'cosmaceutical' products such as Botox. Analysts have seized …
Small and flexible: the manufacturing of tomorrow
March 24, 2009Manufacturing and Production biologics
Biopharmaceutical manufacturing is likely to undergo a dramatic change over the next 20 years, with the today's facilities facing dramatic …
GlaxoSmithKline and UCL to develop biologic
March 24, 2009Research and Development GSK
Researchers at University College London are to work with GlaxoSmithKline to develop a new treatment for the rare and often …
Merck Serono sets up biotech fund
March 24, 2009Research and Development Merck Serono, biotech
Merck Serono has set up a venture capital fund to invest in emerging biotech companies working in its core therapy …
Survey adds pressure for re-think on bowel cancer drugs
March 24, 2009Medical Communications, Sales and Marketing Cancer
A new survey by Beating Bowel Cancer has highlighted the problems facing patients with the condition in getting the best …
Biosimilars: time for an approval pathway in the US
March 23, 2009Research and Development, Sales and Marketing US, generics
Congress has received another bill seeking to establish a biosimilars approval pathway in the US. HR 1427 represents the latest …
Bayer strikes R&D deal with Chinese university
March 20, 2009Research and Development Bayer, China, academic research
Bayer has furthered its R&D expansion in China with an agreement to form a joint pharmaceutical research centre with Tsinghua …
Lundbeck launches sleep awareness campaign
March 20, 2009Sales and Marketing Lundbeck, sleep
Lundbeck has launched a campaign aiming to raise awareness of insomnia and sleep problems. 'Sleep well, Live well ' is …
Shire withdraws ADHD patch filing
March 19, 2009Research and Development, Sales and Marketing Shire
Shire has withdrawn the European marketing application for its Attention Deficit Hyperactivity Disorder (ADHD) patch product Daytrana. The product's active …
Sanofi boosted by Multaq vote of approval
March 19, 2009Research and Development, Sales and Marketing FDA, Multaq, Sanofi, US
An FDA committee has recommended Sanofi-Aventis' new atrial fibrillation treatment Multaq, the company's most important late-stage drug. The FDA cardiovascular …
FDA to review Xarelto safety concerns
March 19, 2009Research and Development, Sales and Marketing Xarelto
Anti-blood clotting drug Xarelto could fail to win approval in the US due to safety concerns. The FDA has convened …
ProStrakan ‘on target’ to break-even this year
March 19, 2009Sales and Marketing ProStrakan
ProStrakan says it will move into the black later this year, after sales rose by a third and its operating …
Biosimilars bill offers 12 years’ marketing exclusivity
March 19, 2009Research and Development US, generics
The US moved one step closer to creating a market for biosimilars – substitutable versions of branded biologic drugs – …
Hamburg appointed as new FDA head
March 18, 2009Research and Development FDA
A leading public health expert has been appointed as the new head of the FDA. President Obama has selected Dr …
Patent office shows tougher stance on “evergreening”
March 18, 2009Research and Development Europe
The rate of patent applications refused in Europe has risen to an all time high, as authorities target "evergreening" of …
Getting the most out of your product portfolio
March 17, 2009Research and Development, Sales and Marketing portfolio, product
Portfolio planning should be a practical process that delivers a programme of work to take you to sunnier shores. All …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
